Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
Disturbed Expression of Type 1 Iodothyronine Deiodinase Splice Variants in Human Renal Cancer
Thyroid, 06/26/09
Piekielko-Witkowska A et al. - The results show that the expression and alternative splicing of DIO1 mRNA is disturbed in renal cancer, possibly due to changes in expression of splicing factors SF2/ASF and hnRNPA1.
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Fibroblast growth factor 23 and the future of phosphorus management
Current Opinion in Nephrology and Hypertension, 10/15/09
The balance of autocrine VEGF-A and VEGF-C determines podocyte survival
American Journal of Physiology: Renal Physiology, 10/15/09
Simultaneous Infiltration of Polyfunctional Effector and Suppressor T Cells into Renal Cell Carcinomas
Cancer Research, 11/03/09
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Pseudopheochromocytoma: An uncommon cause of malignant hypertension
Indian Journal of Nephrology, 10/16/09
Upfront, randomized, phase II trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma
Cancer, 11/03/09
New treatment approaches in renal cell carcinoma
Anti-Cancer Drugs, 10/15/09
Article Search
Sponsor


See Latest Articles


